A Study comparing two different doses of Injection Buprenorphine when added to Injection Levobupivacaine (0.5% concentration) for ultrasound guided supraclavicular brachial plexus nerve block in elective upper limb surgeries.

A comparative study between two different doses of buprenorphine as an adjuvant to 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063894

Enrollment

Registered

2024-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: S529- Unspecified fracture of forearm

Interventions

Intervention1: Levobupivacaine Plus Buprenorphine: Supraclavicular brachial plexus block with 20 ml 0.5% Levobupivacaine plus 2 microgram per kilogram buprenorphine under ultrasound guidance. Interve

Eligibility

Inclusion criteria

Inclusion criteria: patient of asa physical grade 2 18 to 65 year age both sexes posted for elective surgeries of upper limb

Exclusion criteria

Exclusion criteria: history of infection at the site of block coagulopathies patient with known hypersensitivity to lacal anaesthetics pregnant women preexisting coagulopathies neck deformities

Design outcomes

Primary

Measure	Time frame
1)Heart rate 2)Mean arterial pressure 3)SaturationTimepoint: 1)Time at which procedure of giving block is finished. 2)Five minute 3)Ten minute 3)Fifteen minute 4)Twenty minute 5)Fourty minute	—

Secondary

Measure	Time frame
1.Heart rate 2.Mean arterial pressure 3.Intraoperative sedation score Timepoint: 1)Sixty minute 2)Eighty minute 3)Hundred minute 4)One twenty minute 5)One fourty minute	—

Countries

India

Contacts

Public ContactDr Pramod bhale

Mgm medical college

pramod.bhale@gmail.com8888819021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026